Search results for "TUMORS"

showing 10 items of 1138 documents

Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring

2022

Ki-67 assessment is a key step in the diagnosis of neuroendocrine neoplasms (NENs) from all anatomic locations. Several challenges exist related to quantifying the Ki-67 proliferation index due to lack of method standardization and inter-reader variability. The application of digital pathology coupled with machine learning has been shown to be highly accurate and reproducible for the evaluation of Ki-67 in NENs. We systematically reviewed all published studies on the subject of Ki-67 assessment in pancreatic NENs (PanNENs) employing digital image analysis (DIA). The most common advantages of DIA were improvement in the standardization and reliability of Ki-67 evaluation, as well as its spee…

Reproducibility of ResultsBreast NeoplasmsCarcinoid TumorPathology and Forensic MedicinePancreatic Neoplasmsneuroendocrine neoplasms pancreasNeuroendocrine TumorsKi-67 AntigenGastroenteropancreatic Neuroendocrine TumorBiomarkers TumorImage Processing Computer-AssistedHumansGastroenteropancreatic Neuroendocrine Tumor; Cancer; Carcinoid TumorFemaleCell ProliferationCancer
researchProduct

Early rehabilitation of cancer patients - a randomized controlled intervention study.

2013

Published version of an article in the journal: BMC Cancer. Also available from the publisher at: http://dx.doi.org/10.1186/1471-2407-13-9 Open access Background: Faced with a life-threatening illness, such as cancer, many patients develop stress symptoms, i.e. avoidance behaviour, intrusive thoughts and worry. Stress management interventions have proven to be effective; however, they are mostly performed in group settings and it is commonly breast cancer patients who are studied. We hereby present the design of a randomized controlled trial (RCT) evaluating the effectiveness and cost-effectiveness of an individual stress-management intervention with a stepped-care approach in several cance…

Research designCounselingMaleCancer ResearchMedicin och hälsovetenskapTime Factorsmedicine.medical_treatmentCost-Benefit AnalysisAnxietyVDP::Medisinske fag: 700::Klinisk medisinske fag: 750::Onkologi: 762Medical and Health Scienceslaw.inventionStress Disorders Post-TraumaticStudy ProtocolRandomized controlled trialCost of IllnesslawNeoplasmsSurveys and QuestionnairesActivities of Daily LivingAdaptation PsychologicalLongitudinal StudiesProspective StudiesHospital CostsIndividual stress managementProspective cohort studyFatiguemedia_commonDepressionAdjuvant/curative therapyVDP::Medical disciplines: 700::Health sciences: 800lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensMental HealthTreatment OutcomeOncologyResearch DesignVDP::Midical sciences: 700::Clinical medical sciences: 750::Oncology: 762FemaleWorryMental Health ServicesSleep Wake Disordersmedicine.medical_specialtyImpact of event scalePsychometricsmedia_common.quotation_subjectMotor Activitylcsh:RC254-282Breast cancerIntervention (counseling)GeneticsmedicineHumansRCT with stepped-care approachMotivationCognitive Behavioral Therapybusiness.industryPhysical activityCancermedicine.diseasePhysical therapyCognitive therapyQuality of LifebusinessSleepStress PsychologicalBMC cancer
researchProduct

Missing Evidences in Cancer Genetics: The Retinoblastoma Paradigm

2008

BACKGROUND: Retinoblastoma (Rb) is the most common primary malignant intraocular tumour in childhood. The "two hit" theory, formulated by Knudson in 1971 to explain the variegated clinical expression of the disease, led to the discovery of the so called tumour suppressor genes and the identification of the Rb1 as the prototype of such genes. Mutations of the Rb1 gene are now commonly believed to be the "cause" retinoblastoma, although epidemiological, clinical, and biological evidences argue against it. MATERIAL/METHODS: The Authors have performed a systematic review of available data concerning clinical and diagnostic aspects of retinoblastoma, including molecular genetics. Meta analysis o…

Retinoblastoma pRBCancer Researchlcsh:CytologyRetinoblastomaCell BiologyGeneral Medicinelcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282Retinoblastoma ProteinPathology and Forensic MedicineMutationHumansMolecular MedicineGenetic Predisposition to Diseaselcsh:QH573-671Letter to the EditorCellular Oncology : the Official Journal of the International Society for Cellular Oncology
researchProduct

Morbidity and mortality after esophagectomy for esophageal carcinoma: A risk analysis

2005

Abstract Background The study was aimed to identify pre- and intraoperative risk factors that potentially influence morbidity and mortality after esophagectomy for esophageal carcinoma with particular emphasis on the predominant tumor types. Patients and methods Between September 1985 and March 2004, 424 patients underwent esophagectomy for esophageal carcinoma. Of these, 186 (43.9%) patients had a transhiatal, and 231 (54.5%) patients underwent a transthoracic procedure with two-field lymphadenectomy. Pre-, intraoperative risk factors and tumor characteristics were included in the risk analysis to assess their influence on postoperative morbidity and mortality. Results Multivariate analysi…

Risk analysismedicine.medical_specialtybusiness.industryMortality ratemedicine.medical_treatmentResearchlcsh:Surgerylcsh:RD1-811medicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282SurgeryOncologyRisk analysis (engineering)EsophagectomyIntensive caremedicineCarcinomaAdenocarcinomaSurgeryLymphadenectomyRisk factorbusinessWorld Journal of Surgical Oncology
researchProduct

Controversial issues in soft tissue solitary fibrous tumors: A pathological and molecular review

2019

The clinical evolution of solitary fibrous tumor (SFT) remains unclear. Although various clinical, morphological and molecular criteria may indicate increased risk of malignancy, some SFT can still progress despite having a clearly benign appearance. Various risk stratification systems have been proposed, but unfortunately they are not sufficient to precisely determine the malignant potential. In this review, we discuss current knowledge on SFT, focusing on the following controversial issues: (i) the diverse morphologic spectrum: 'the great simulator;' (ii) malignant transformation or dedifferentiation; (iii) current risk stratification systems; and (iv) molecular factors associated with cl…

Risk0301 basic medicinePathologymedicine.medical_specialtySolitary fibrous tumorMalignancyPathology and Forensic MedicineMalignant transformationDiagnosis Differential03 medical and health sciences0302 clinical medicinemedicineHumansPathologicalbusiness.industrySoft tissueGeneral MedicineCell DedifferentiationPrognosismedicine.diseaseImmunohistochemistryCell Transformation Neoplastic030104 developmental biologyIncreased riskSolitary Fibrous Tumors030220 oncology & carcinogenesisRisk stratificationbusinessPathology International
researchProduct

Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy.

2012

BACKGROUND. The objective of this study was to compare the prognostic relevance of Response Evaluation Criteria in Solid Tumors (RECIST) versus Choi criteria for the assessment of response in patients with high-risk soft tissue sarcoma of the extremities or trunk wall who received preoperative chemotherapy with or without radiotherapy in a phase 3 trial. METHODS. Patients received 3 cycles of preoperative epirubicin þ ifosfamide with or without radiotherapy. The diagnostic concordance between RECIST and Choi criteria and their correlation with overall survival (OS) and freedom from progression (FFP) were evaluated in a univariate Cox regression model. RESULTS. In 243 of 321 eligible patient…

RiskCancer Researchmedicine.medical_specialtymedicine.medical_treatmentchemotherapymedicineHumansResponse Evaluation Criteria in Solid TumorsProbabilityProportional Hazards ModelsRetrospective Studiesresponse assessmentIfosfamideProportional hazards modelbusiness.industrySoft tissue sarcomachemotherapy; Choi criteria; outcome; prognosis; response assessment; Response Evaluation Criteria in Solid Tumors; sarcoma; Cancer Research; OncologySarcomamedicine.diseasePrognosisSurgeryRadiation therapyChoi criteriaOncologyResponse Evaluation Criteria in Solid TumorsoutcomeRadiologySarcomabusinessProgressive diseasemedicine.drugEpirubicinCancer
researchProduct

Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations : Results from a Multi-institutional European Retrospective Study

2022

[Purpose] The effect of high-dose imatinib (800 mg/day) on survival in the adjuvant treatment of patients with resected KIT exon 9–mutated gastrointestinal stromal tumors (GIST) is not established. Here, the association of dose and other clinicopathologic variables with survival was evaluated in a large multi-institutional European cohort.

STRUCTURAL BASISEXPRESSIONOncologyCancer Researchmedicine.medical_specialtyGastrointestinal Stromal Tumors3122 CancersMedizinAntineoplastic Agentsexon 9Adjuvants ImmunologicInternal medicinemedicineHumansFAILURERetrospective StudiesRISKRECEPTORGiSTProportional hazards modelbusiness.industryGASTROINTESTINAL STROMAL TUMORSHazard ratioImatinibRetrospective cohort studyExonsAdjuvant treatmentConfidence intervalGENOTYPEProto-Oncogene Proteins c-kitOncologyChemotherapy AdjuvantMutationPropensity score matchingCohortImatinib MesylateNeoplasm Recurrence LocalTYROSINE KINASE INHIBITORbusinessRare cancers Radboud Institute for Health Sciences [Radboudumc 9]medicine.drugGIST
researchProduct

Near-Haploidy in a Malignant Sacrococcygeal Teratoma

1999

Cytogenetic analysis of a malignant sacrococcygeal teratoma in an adult patient revealed near-haploid (77%), near-diploid (19%), and polyploid (4%) cells. The near-haploid cells had a karyotype of 25,XX,der(5)t(5;7)(p15;p13),+7,der(9)t(6;9)(p21;q34),r(17)(p13q25) . In the near-diploid and polyploid cells identical copies of the structural chromosomal changes were found. Although some of the anomalies observed appear unique to this case, a common breakpoint in chromosome 6 was previously reported as specific in a subgroup of extragonadal germ cell tumors of adults.

SacrumCancer Researchmedicine.medical_specialtyPathologyNear-HaploidyExtragonadalChromosomal translocationHaploidyBiologyTranslocation GeneticPolyploidyFatal OutcomeGeneticsmedicineHumansMolecular BiologyAgedCoccyxPloidiesSpinal NeoplasmsfungiTeratomaCytogeneticsChromosome MappingChromosomeKaryotypeAnatomymedicine.diseaseDiploidyKaryotypingChromosomes Human Pair 5Chromosomes Human Pair 6FemaleGerm cell tumorsChromosomes Human Pair 9Tomography X-Ray ComputedSacrococcygeal teratomaChromosomes Human Pair 7Cancer Genetics and Cytogenetics
researchProduct

The Chaperone System in Salivary Glands: Hsp90 Prospects for Differential Diagnosis and Treatment of Malignant Tumors

2022

Salivary gland tumors represent a serious medical problem and new tools for differential diagnosis and patient monitoring are needed. Here, we present data and discuss the potential of molecular chaperones as biomarkers and therapeutic targets, focusing on Hsp10 and Hsp90. The salivary glands are key physiological elements but, unfortunately, the information and the means available for the management of their pathologies, including cancer, are scarce. Progress in the study of carcinogenesis has occurred on various fronts lately, one of which has been the identification of the chaperone system (CS) as a physiological system with presence in all cells and tissues (including the salivary gland…

Settore BIO/16 - Anatomia UmanaOrganic ChemistryAntineoplastic AgentsGeneral MedicineSettore MED/08 - Anatomia PatologicaSalivary Gland NeoplasmsSalivary GlandsCatalysisComputer Science ApplicationsDiagnosis DifferentialInorganic ChemistryHumanschaperone system differential diagnosis Ganetespib Hsp90 Hsp90 biomarker Hsp90 pathogenic negative chaperonotherapysalivary gland tumors Diagnosis Differential Humans Molecular Chaperones Salivary Glands Antineoplastic Agents Salivary Gland NeoplasmsHSP90 Heat-Shock ProteinsPhysical and Theoretical Chemistrysalivary gland tumors; chaperone system; Hsp90; Hsp90 pathogenic; negative chaperonotherapy; Ganetespib; Hsp90 biomarker; differential diagnosisMolecular BiologySpectroscopyMolecular Chaperones
researchProduct

Expression of gelatinases (MMP-2, MMP-9) and cyclooxygenases (COX-1, COX-2) in some benign salivary gland tumors.

2012

Salivary gland tumors, most of which are rare benign tumors, represent a histologically heterogenous group with the greatest diversity of morphological and cellular features. The aim of this study is to analyse the expression and possible interactions between gelatinases (MMP-2, MMP-9) and cyclooxygenases (COX-1, COX-2) in some benign salivary gland tumors. We investigated the expression of gelatinases and cyclooxigenases in control salivary gland, Pleomorphic adenoma and Warthin's tumor through immunohistochemistry and Reverse Transcription – Polymerase Chain Reaction (PCR). We identified the expression of both classes of enzyme in normal samples and in the two types of pathological sampl…

Settore BIO/17 - IstologiaGelatinasesPathologymedicine.medical_specialtyImmunologyAdenoma PleomorphicBiologyMatrix metalloproteinaselaw.inventionPleomorphic adenomalawSettore MED/28 - Malattie OdontostomatologichemedicineHumansImmunology and AllergyProspective StudiesPathologicalPolymerase chain reactionPharmacologySalivary glandReverse Transcriptase Polymerase Chain Reactionbenign salivary gland tumorsgelatinasescyclooxygenasesAdenolymphomaSalivary Gland Neoplasmsmedicine.diseaseImmunohistochemistryReverse transcriptasemedicine.anatomical_structureSettore MED/31 - OtorinolaringoiatriaMatrix Metalloproteinase 9Cyclooxygenase 2Cyclooxygenase 1Matrix Metalloproteinase 2Immunohistochemistry
researchProduct